Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abeona Therapeutics (ABEO) Treasury Shares (2020 - 2025)

Abeona Therapeutics has reported Treasury Shares over the past 4 years, most recently at $4000.0 for Q3 2014.

  • Quarterly results put Treasury Shares at $4000.0 for Q3 2014, changed 0.0% from a year ago — trailing twelve months through Sep 2014 was $4000.0 (changed 0.0% YoY), and the annual figure for FY2013 was $4000.0, changed 0.0%.
  • Treasury Shares for Q4 2025 was $4.2 million at Abeona Therapeutics, up from $4.1 million in the prior quarter.
  • Over the last five years, Treasury Shares for ABEO hit a ceiling of $5.3 million in Q1 2025 and a floor of $61108.0 in Q2 2022.
  • Median Treasury Shares over the past 5 years was $2.4 million (2023), compared with a mean of $2.4 million.
  • Peak annual rise in Treasury Shares hit 0.0% in 2012, while the deepest fall reached 0.0% in 2012.
  • Abeona Therapeutics' Treasury Shares stood at $4000.0 in 2011, then changed by 0.0% to $4000.0 in 2012, then changed by 0.0% to $4000.0 in 2013, then changed by 0.0% to $4000.0 in 2014.
  • The last three reported values for Treasury Shares were $4000.0 (Q3 2014), $4000.0 (Q2 2014), and $4000.0 (Q1 2014) per Business Quant data.